New insights into insulin dependent diabetes mellitus from studies with transgenic mouse models

Laboratory Investigation

Volumn 76, Issue 1, 1997, Pages 3-10

  Grewal, Iqbal S ^a   Flavell, Richard A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; GENE EXPRESSION REGULATION; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE SUBPOPULATION; TECHNOLOGY; TRANSGENIC MOUSE;

ANIMALS; ANTIGEN-PRESENTING CELLS; CYTOKINES; DIABETES MELLITUS, TYPE 1; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; ISLETS OF LANGERHANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTE SUBSETS;

EID: 0031025193     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (61)

1. Adams TE, Alpert S, and Hanahan D (1987). Non-tolerance and autoantibodies to a transgenic self antigen expressed in pancreatic beta cells. Nature 325:223-228.
2. Allison J, McClive P, Oxbrow L, Baxter A, Morahan G, and Miller JF (1994a). Genetic requirements for acceleration of diabetes in non-obese diabetic mice expressing interleukin-2 in islet beta-cells. Eur J Immunol 24:2535-2541.
3. Allison J, Oxbrow L, and Miller, JF (1994b). Consequences of in situ production of IL-2 for islet cell death. Int Immunol 6:541-549.
4. Arai KI, Lee F, Miyajima A, Miyatake S, Arai N, and Yokota T (1990). Cytokines: Coordinators of immune and inflammatory responses. Annu Rev Biochem 59:783-836.
5. Arnold B, Schonrich G, and Hammerling GJ (1993). Multiple levels of peripheral tolerance. Immunol Today 14:12-14.
6. Blackman M, Kappler J, and Marrack P (1990). The role of the T cell receptor in positive and negative selection of developing T cells. Science 248:1335-1341.
7. Campbell IL, Hobbs MV, Dockter J, Oldstone MB, and Allison J (1994). Islet inflammation and hyperplasia induced by the pancreatic islet-specific overexpression of interleukin-6 in transgenic mice. Am J Pathol 145:157-166.
8. Campbell IL, Kay TW, Oxbrow L, and Harrison LC (1991). Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J Clin Invest 87:739-742.
9. Collins AR (1990). Comparison of the replication of distinct strains of human coronavirus OC43 in organotypic human colon cells (Caco-2) and mouse intestine. Adv Exp Med Biol 276:497-503.
10. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, and Trinchieri G (1993). Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 178:1041-1048.
11. de Waal Maleyft R, Yssel H, Roncarolo MG, Spits H, and de Vries JE (1992). Interleukin-10. Curr Opin Immunol 4:314-320.
12. DiCosmo BF, Picarella D, and Flavell RA (1994). Local production of human IL-6 promotes insulitis but retards the onset of inslin-dependent diabetes mellitus in non-obese diabetic mice. Int Immunol 6:1829-1837.
13. Ding L, and Shevach EM (1992). IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J Immunol 148:3133-3139.
14. Elliott EA, and Flavell RA (1994). Transgenic mice expressing constitutive levels of IL-2 in islet beta cells develop diabetes. Int Immunol 6:1629-1637.
15. Erat S, Fusco-DeMane D, Lemberg H, al Emran O, and Wang X (1995). Conditional transformation of a tetracycline-regulated oncogene. Proc Natl Acad Sci U S A 92:3576-3580.
16. Finkelman, FD, Svetic A, Gresser I, Snapper C, Holmes J, Trotta PP, Katona IM, and Gause WC (1991). Regulation by interferon alpha of immunoglobulin isotype selection and lymphokine production in mice. J Exp Med 174:1179-1188.
17. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, and O'Garra A (1991). IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146:3444-3451.
18. Flavell RA, Kratz A, and Ruddle NH (1996). The contribution of insulitis to diabetes development in tumor necrosis factor transgenic mice. Curr Top Microbiol Immunol 206:33-50.
19. Gossen M and Bujard H (1992). Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89:5547-5551.
20. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, and Bujard H (1995). Transcriptional activation by tetracyclines in mammalian cells. Science 268:1766-1769.
21. Grewal IS, Grewal KD, Wong FS, Picarella D, Janeway CA Jr, and Flavell R (1996). Local expression of transgene encoded TNFa in islets prevents autoimmune diabetes in NOD mice by preventing the development of auto-reactive islet specific T cells. J Exp Med 184:1963-1974.
22. Guerder S, Picarella DE, Linsley PS, and Flavell RA (1994a). Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor alpha leads to autoimmunity in transgenic mice. Proc Natl Acad Sci USA 91:5138-5142.
23. Guerder S, Meyerhoff J, and Flavell R (1994b). The role of the T cell costimulator B7-1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen. Immunity 1:155-166.
24. Hanahan D (1990). Transgenic mouse models of self-tolerance and autoreactivity by the immune system. Annu Rev Cell Biol 6:493-537.
25. Harlan DM, Hengartner H, Huang ML, Kang YH, Abe R, Moreadith RW, Pircher H, Gray GS, Ohashi PS, and Freeman GJ (1994). Mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness. Proc Natl Acad Sci U S A 91:3137-3141.
26. Haskins K, Portas M, Bergman B, Lafferty K, and Bradley B (1989). Pancreatic islet-specific T-cell clones from nonobese diabetic mice. Proc Natl Acad Sci U S A 86-8000-8004.
27. Healey D, Ozegbe P, Arden S, Chandler P, Hutton J, and Cooke A (1995). In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice. J Clin Invest 95:2979-2985.
28. Higuchi Y, Herrera P, Muniesa P, Huarte J, Belin D, Ohashi P, Aichele P, Orci L, Vassalli J, and Vassalli P (1992). Expression of a tumor necrosis facotr alpha transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes. J Exp Med 176:1719-1731.
29. Katz JD, Wang B, Haskins K, Benoist C, and Mathis D (1993). Following a diabetogenic T cell from genesis through pathogenesis. Cell 74:1089-1100.
30. Katz JD, Benoist C, and Mathis D (1995). T helper cell subsets in insulin-dependent diabetes. Science 268:1185-1188.
31. Kroemer G and Wick G (1989). The role of interleukin 2 in autoimmunity. Immunol Today 10:246-251.
32. Kroemer G, Andreu JL, Gonzalo JA, Gutierrez-Ramos JC, and Martinez C (1991). Interleukin-2, autotolerance, and autoimmunity. Adv Immunol 50:147-235.
33. Lanier LL, Spits H, and Phillips JH (1992). The developmental relationship between NK cells and T cells. Immunol Today 13:392-395.
34. Lee MS, von Herrath M, Resier H, Oldstone MB, and Sarvetnick N (1995). Sensitization to self (virus) antigen by in situ expression of murine interferon-gamma. J Clin Invest 95:486-492.
35. Liblau R, Singer S, and McDevitt H (1995). Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 16:34-38.
36. Lipes MA, Rosenzweig A, Tan KN, Tanigawa G, Ladd D, Seidman JG, and Eisenbarth GS (1993). Progression to diabetes in nonobese diabetic (NOD) mice with transgenic T cell receptors (comment). Science 259:1165-1169.
37. Lo D, Freedman J, Hesse S, Palmiter RD, Brinster RL, and Sherman LA (1992). Peripheral tolerance to an islet cell-specific hemagglutinin transgene affects both CD4+ and CD8+ T cells. Eur J Immunol 22:1013-1022.
38. Miller J and Morahan G (1992). Peripheral T cell tolerance. Annu Rev Immunol 10:51-69.
39. Mueller R, Krahl T, and Sarvetnick N (1996). Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic mice. J Exp Med 184:1093-1099.
40. Ohashi PS, Oehen S, Buerki K, Pircher H, Ohashi CT, Odermatt B, Malissen B, Zinkernagel RM, and Hengartner H (1991). Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65:305-317.
41. Oldstone MB, Nerenberg M, Southern P, Price J, and Lewicki H (1991). Virus infection triggers insulin-dependent diabetes mellitius in a transgenic model: Role of anti-self (virus) immune response. Cell 65:319-331.
42. Oldstone MB, von Herrath M, Evans CF, and Horwitz MS (1996). Virus-induced autoimmune disease: Transgenic approach to mimic insulin-dependent diabetes mellitus and multiple sclerosis. Curr Top Microbiol Immunol 206:67-83.
43. Ozes ON, Reiter Z, Klein S, Blatt LM, Taylor MW, Miller JF, and Morahan G (1992). A comparison of interferon-Con1 with natural recombinant interferons-alpha: Antiviral, antiproliferative, and natural killer-inducing activities. J Interferon Res 12:55-59.
44. Picarella DE, Kratz A, Li CB, Ruddle NH, and Flavell RA (1992). Insulitis in transgenic mice expressing tumor necrosis factor beta (lymphotoxin) in the pancreas. Proc Natl Acad Sci USA 89:10036-10040.
45. Picarella DE, Kratz A, Li CB, Ruddle NH, and Flavell RA (1993). Transgenic tumor necrosis factor (TNF)-alpha production in pancreatic islets leads to insulitis, not diabetes: Distinct patterns of inflammation in TNF-alpha and TNF-beta transgenic mice. J Immunol 150:4136-4150.
46. Rabinovitch A (1994). Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM: Therapeutic intervention by immunostimulation? Diabetes 43:613-621.
47. Roman LM, Simons LF, Hammer RE, Sambrook JF, and Gething MJ (1990). The expression of influenza virus hemagglutinin in the pancreatic beta cells of transgenic mice results in autoimmune diabetes. Cell 61:383-396.
48. Sarvetnic N, Liggitt D, Pitts SL, Hansen SE, and Stewart TA (1988). Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell 52:773-782.
49. Sarvetnic N, Shizuru J, Liggitt D, Martin L, McIntyre B, Gregory A, Parslow T, and Stewart T (1990). Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma. Nature 346:844-847.
50. Scott B, Liblau R, Degermann S, Marconi LA, Ogata L, Caton AJ, McDevitt HO, and Lo D (1994). A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1:73-83.
51. Shockett P, Difilippantonio M, Hellman N, and Schatz DG (1995). A modified tetracycline-regulated system provides autoregulatory inducible gene expression in cultured cells and transgenic mice. Proc Natl Acad Sci USA 92:6522-6526.
52. Skowronski J, Jolicoeur C, Alpert S, and Hanahan D (1990). Determinants of the B-cell response against a transgenic autoantigen. Proc Natl Acad Sci USA 87:7487-7491.
53. Soldevila Q, Geiger T, and Flavell RA (1995). Breaking immunologic ignorance to an antigenic peptide of simian virus 40 large T antigen. J Immunol 155:5590-5600.
54. Stewart TA, Hultgren B, Huang X, Pitts-Meek S, Hully J, and MacLachlan NJ (1993). Induction of type I diabetes by interferon-alpha in transgenic mice. Science 260:1942-1946.
55. Tisch R and McDevitt H (1996). Insulin-dependent diabetes mellitus. Cell 85:291-297.
56. von Herrath, MG, Allison J, Miller JF, and Oldstone MB (1995). Focal expression of interleukin-2 does not break unresponsiveness to "self" (viral) antigen expressed in beta cells but enhances development of autoimmune disease (diabetes) after initiation of an anti-self immune response. J Clin Invest 95:477-485.
57. Wicker LS, Todd JA, and Peterson LB (1995). Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol 13:179-200.
58. Wogensen L, Huang X, and Sarvetnick N (1993). Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans. J Exp Med 178:175-185.
59. Wogensen L, Lee MS, and Sarvetnick N (1994). Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice. J Exp Med 179:1379-1384.
60. Wong S, Guerder S, Visintin I, Reich EP, Swenson KE, Flavell RA, and Janeway CA Jr (1995). Expression of the co-stimulator molecule B7-1 in pancreatic beta-cells accelerates diabetes in the NOD mouse. Diabetes 44:326-329.
61. Yssel H, de Waal Malefyt R, Roncarolo MG, Abrams JS, Lahesmaa R, Spits H, and de Vries JE (1992). IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J Immunol 149:2378-2384.